Covid Vaccine Exports Stumble in a Global Race Against Variants

Indian pharmaceutical executive Sai Prasad was speaking for many in the vaccine industry when he criticized the U.S. for blocking shipments of key raw materials needed to produce Covid-19 inoculations.

As his home country battled to contain a devastating fresh wave that has broken its health system and is killing thousands each day, Prasad and other vaccine officials last week blamed the use of the U.S. Defense Production Act to protect American supplies.